August 2013 FDA Recall Drug by Teva Pharmaceuticals Usa, Inc.
D-928-2013 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa, Inc. on August 13, 2013 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-928-2013

Reason for Recall
Lack of Assurance of Sterility: The required reduction of endotoxin was not met during the annual revalidation of the vial washer.
Initiated
08-13-2013
Reported
09-11-2013
Quantity
780 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA, Inc.
CARBOplatin Injection, 600 mg/60ml, MultiDose, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618 NDC 0703-3249-11

Batch or Lot Expiration Information

Lot# Lot 31314458B, 31314459B exp.08/14, 31315794 exp. 10/14, 31315982B exp.11/14